Related Experiment Video
Updated: Nov 16, 2025

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Changes in extracellular water with hemodialysis and fall in systolic blood pressure
Kamonwan Tangvoraphonkchai1, Andrew Davenport2
1Department of Renal Medicine, Mahasarakham University Hospital, Mahasarakham, Thailand.
Insights
Intra-dialytic hypotension (IDH) is common during hemodialysis (HD). This study found that a greater reduction in extracellular volume (ECW) during HD is associated with a drop in systolic blood pressure (SBP), suggesting ECW monitoring could prevent IDH.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Bioengineering
Background:
- Intra-dialytic hypotension (IDH) is a frequent complication during outpatient hemodialysis (HD) sessions.
- Fluid removal during HD leads to extracellular volume (ECW) contraction.
- The relationship between ECW changes and systolic blood pressure (SBP) during HD requires further investigation.
Purpose of the Study:
- To determine if the reduction in ECW during HD is associated with a fall in SBP.
- To identify factors influencing ECW changes and their correlation with hemodynamic stability during dialysis.
Main Methods:
- Retrospective review of adult dialysis outpatients undergoing midweek HD sessions.
- Pre- and post-HD bioimpedance measurements of ECW were analyzed.
- Correlation and logistic regression models were used to assess associations between ECW, SBP, and other clinical variables.
Main Results:
- A significant association was observed between the percentage fall in ECW (ECW%) and post-dialysis SBP (r = -0.14, p < 0.001).
- Patients experiencing SBP falls >20 mmHg showed a greater ECW% reduction compared to those with stable SBP.
- Increased ECW% fall was linked to weight loss, longer session duration, and negatively correlated with hemodiafiltration and dialysate sodium-to-plasma gradient.
Conclusions:
- A clear association exists between ECW reduction and SBP changes during dialysis.
- Monitoring ECW fluctuations during HD is recommended.
- Developing biofeedback devices to manage ultrafiltration and dialysate sodium could mitigate IDH risk.
Introduction:
Intra-dialytic hypotension (IDH) remains the most common complication with outpatient hemodialysis (HD) sessions. As fluid is removed during HD, there is contraction of the extracellular volume (ECW). We wished to determine whether the fall in ECW was associated with a fall in systolic blood pressure (SBP).
Methods:
We retrospectively reviewed the records of adult dialysis outpatients attending for their midweek sessions who had corresponding pre- and post-HD bioimpedance measurements of ECW.
Result:
We reviewed 736 patients, median age 67 (54-76) years, 62.8% male, 45.7% diabetic with a median dialysis vintage of 24.4 (9.2-56.8) months. The percentage fall in ECW (ECW%) was associated with post-dialysis systolic blood pressure (SBP) (r = -0.14, p < 0.001). Patients with SBP falls of >20 mmHg had a greater fall in ECW% compared to patients with stable SBP 7.6 (4.6-10.1) vs 6.0 (4.0-8.5), p < 0.001). Patients with greater dialyzer urea clearance had greater fall in ECW% (r = 0.19, p < 0.001). In a logistic model an increased fall in ECW% was associated with weight loss (odds ratio (OR) 1.88, 95% confidence limits (CL) 1.62-2.176, p < 0.001), and session duration (OR 1.45 (CL 1.05-1.99), p = 0.024), and negatively with hemodiafiltration compared to hemodialysis (OR 0.37 (0.19-0.74) p = 0.005 and dialysate sodium to plasma gradient (OR 0.95 (CL 0.90-0.99), p = 0.021).
Conclusion:
We observed an association between the reduction in ECW and SBP with dialysis. Our results would advocate monitoring ECW changes during dialysis and developing biofeedback devices to control ultrafiltration and dialysate sodium to reduce the risk of IDH.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Regulation of Water Output
Hemodialysis III: Nursing Management
Antihypertensive Drugs: Action of Diuretics
Regulation of Water Intake
Heart Failure Drugs: Diuretics

